As the medication reduces appetite and increases satiety, individuals tend to eat fewer calories, which contributes to weight loss over time
Blood work to assess thyroid function, insulin levels, hormone balance, and vitamin deficiencies can reveal underlying issues
Science 187 , 544547 (1975)
Food and Drug Administration (FDA), the approved dosages for some of the commonly prescribed GLP-1 agonists are as follows: Semaglutide (Ozempic): 0.5 mg, 1 mg, or 2 mg once weekly for type 2 diabetes, and up to 2.4 mg once weekly for chronic weight management (marketed as Wegovy)
By influencing appetite regulation and blood glucose stability, the medication can reduce the likelihood of progression toward type 2 diabetes and improve metabolic control in patients already managing insulin resistance